These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11869699)

  • 1. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
    Guadagni S; Russo F; Rossi CR; Pilati PL; Miotto D; Fiorentini G; Deraco M; Santinami M; Palumbo G; Valenti M; Amicucci G
    Am J Surg; 2002 Jan; 183(1):28-36. PubMed ID: 11869699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
    Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
    Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic pelvic perfusion with mitomycin C using a simplified balloon-occlusion technique in the treatment of patients with unresectable locally recurrent rectal cancer.
    Guadagni S; Fiorentini G; Palumbo G; Valenti M; Russo F; Cantore M; Deraco M; Vaglini M; Amicucci G
    Arch Surg; 2001 Jan; 136(1):105-12. PubMed ID: 11146790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected hypoxic stop-flow perfusions: indication and limits.
    Guadagni S; Kanavos E; Schietroma M; Fiorentini G; Amicucci G
    Tumori; 2006; 92(5):402-6. PubMed ID: 17168432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.
    Noorda EM; Takkenberg B; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Hart GA; Kroon BB
    Ann Surg Oncol; 2004 May; 11(5):491-9. PubMed ID: 15078633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic isolated limb perfusion (ILP) in the management of patients with advanced or recurrent limb melanoma.
    Khan MA; Lanitis S; Desai AP; Rosin RD
    Ir J Med Sci; 2012 Mar; 181(1):157. PubMed ID: 21959950
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases.
    Pace M; Gattai R; Mascitelli EM; Millanta L
    J Surg Oncol; 2011 Dec; 104(7):718-23. PubMed ID: 21721008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional isolated perfusion of extremities for melanoma: a 20-year experience with drugs other than L-phenylalanine mustard.
    Ariyan S; Poo WJ; Bolognia J
    Plast Reconstr Surg; 1997 Apr; 99(4):1023-9. PubMed ID: 9091898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
    Turk PS; Belliveau JF; Darnowski JW; Weinberg MC; Leenen L; Wanebo HJ
    Arch Surg; 1993 May; 128(5):533-8; discussion 538-9. PubMed ID: 7683872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
    Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
    J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
    Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases.
    Pilati P; Mocellin S; Miotto D; Fittà C; Casara D; Ori C; Scalerta R; Nitti D; Lise M; Rossi CR
    Oncol Rep; 2004 Oct; 12(4):895-901. PubMed ID: 15375519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients.
    Guadagni S; Zoras O; Fiorentini G; Masedu F; Lasithiotakis K; Sarti D; Farina AR; Mackay AR; Clementi M
    J Surg Res; 2021 Dec; 268():737-747. PubMed ID: 34253376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective therapy: repeat limb perfusion for recurrent melanoma.
    Krementz ET
    J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated isolated limb perfusion in melanoma patients with recurrent in-transit metastases.
    Deroose JP; Grünhagen DJ; Eggermont AM; Verhoef C
    Melanoma Res; 2015 Oct; 25(5):427-31. PubMed ID: 26110555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.